Indeed, a recent study by Yeung et al. showed a high expression of CSF-1 receptor on macrophages within the meningioma microenvironment, and treatment with monoclonal antibodies targeting this signaling pathway was associated with decreased meningioma growth in murine models [85]. This evidence concerns the gene CSF1R and meningioma.